An official website of the United States government
Home
A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Category | Primary Site | Code? |
|---|---|---|---|
| tgDCC-E1A | Biologic therapy (BRM, immunotherapy) | Head & neck, ovarian cancer | Yes |
| sibrotuzumab | Chemotherapy | Breast, colorectal, lung, other cancer, pancreatic | Yes |
| sT4 | AIDS drug | No | |
| rgp120/HIV-1 (IIIB) | AIDS drug | No | |
| rgp120 CHO | AIDS drug | No | |
| recMAGE-A3+AS15 | Biologic therapy (BRM, immunotherapy) | Melanoma, NSCLC | Yes |
| radiotherapy | Radiation | Yes | |
| rV-MART-1 | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rV-GP100 | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rF-gp100 | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rF-Tyrosine Vaccine | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rF-Mgp100 | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rF-MART-1 | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| rCD4 | AIDS drug | No | |
| pivaloyloxymethylbutyrate | Chemotherapy | Liver, lung cancer | Yes |
| p53 Tumor Suppressor Gene | Biologic therapy (BRM, immunotherapy) | Head & neck, liver, ovarian cancer | Yes |
| hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482 | Chemotherapy | Kidney | Yes |
| hR3 | Biologic therapy (BRM, immunotherapy) | Head & neck cancer | Yes |
| hIL13-PE38QQR (ligand targeted toxin) | Chemotherapy | Kidney cancer | Yes |
| gp100 Plasmid Vector in Gold Particles | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| gp100 Peptide Vaccine | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| gp100 DNA Vaccine | Biologic therapy (BRM, immunotherapy) | Skin cancer | Yes |
| diazooxonorleucine | Chemotherapy | Skin cancer | Yes |
| dabrafenib | Chemotherapy | Melanoma, Lung, Thyroid | Yes |
| cAC10-vcMMAE(4) | Chemotherapy | Hodgkin lymphoma | Yes |
| avutometinib/defactinib | Chemotherapy | Ovary, | Yes |
| anti-Tac(Fv)-PE38 (immunotoxin) | Biologic therapy (BRM, immunotherapy) | Leukemia | Yes |
| anti-CD72 | Biologic therapy (BRM, immunotherapy) | Leukemia | Yes |
| Zynyz | Biologic therapy (BRM, immunotherapy) | Yes | |
| Zynlonta | Biologic therapy (BRM, immunotherapy) | Yes | |
| Zykadia | Chemotherapy | Lung | Yes |
| Zydelig | Chemotherapy | Yes | |
| Zosuquidar | Ancillary Agent | No | |
| Zorubicin | Chemotherapy | Yes | |
| Zongertinib | Chemotherapy | lung | Yes |
| Zoledronic acid | Ancillary Agent | No | |
| Zoladex | Hormones and hormonal mechanisms | Breast, prostate cancer | Yes |
| Zirabev | Biologic therapy (BRM, immunotherapy) | Yes | |
| Zinostatin | Chemotherapy | Yes | |
| Ziihera | Biologic therapy (BRM, immunotherapy) | Bile ducts, Gall bladder | Yes |
| Ziftomenib | Chemotherapy | Yes | |
| Ziextenzo | Ancillary Agent | No | |
| Zidovudine | AIDS drug | No | |
| Zevalin | Radiation | Lymphoma | Yes |
| Zeniplatin | Chemotherapy | Yes | |
| Zanubrutinib | Chemotherapy | Yes | |
| Zanolimumab | Biologic therapy (BRM, immunotherapy) | Cutaneous T-cell lymphoma, mycosis fungoides | Yes |
| Zamyl | Biologic therapy (BRM, immunotherapy) | Leukemia | Yes |
| Zalutumumab | Chemotherapy | H&N, NSCLC | Yes |
| Zaltrap | Chemotherapy | Colorectal | Yes |
| Zalcitabine | AIDS drug | No | |
| ZYC300 | Biologic therapy (BRM, immunotherapy) | Breast, colon, kidney, ovary, prostate | Yes |
| ZK Epothilone | Chemotherapy | breast, Prostate | Yes |
| ZD6126 | Chemotherapy | Breast, cervical, endometrial, other cancer, ovarian | Yes |
| ZD0473 | Chemotherapy | Lung, ovarian Cancer | Yes |
| Yoshi-864 | Chemotherapy | Yes | |
| Yescarta | Biologic therapy (BRM, immunotherapy) | Yes | |
| YMB-1003MAb | Biologic therapy (BRM, immunotherapy) | Colorectal cancer | Yes |
| YM598 | Chemotherapy | Pancreatic caner | Yes |
| Y-CEA-Cide | Radiation | Pancreatic cancer | Yes |
| Xyotax | Chemotherapy | Breast, colorectal, lung, ovarian cancer | Yes |
| Xpovio | Chemotherapy | Yes | |
| Xofigo | Radiation | Metastatic prostate cancer | Yes |
| Xermelo | Ancillary Agent | No | |
| Xerecept | Ancillary Agent | Brain cancer | Yes |
| Xcytrin | Ancillary Agent | Brain, Lung cancer | No |
| Xcellerate | Biologic therapy (BRM, immunotherapy) | Kidney, prostate cancer | Yes |
| Xalkori | Chemotherapy | Non Small Cell Lung Cancer (NSCLC) | Yes |
| Xaliproden | Ancillary Agent | No | |
| XL-888 | Chemotherapy | Failed first course, melanoma, mets, NSCLC, or unresectable: breast | Yes |
| XL-765 | Chemotherapy | breast, Malignant glioma, NSCLC | Yes |
| XL-281 | Chemotherapy | colorectal, melanoma, NSC, papillary thyroid | Yes |
| XL-184 | Chemotherapy | GBM, NSCLC, solid tumors, Thyroid | Yes |
| XL-147 | Chemotherapy | Advanced Endometrium, lymphoma, Mets breast, NSCLC, ovarian | Yes |
| XL-139 | Chemotherapy | GE and esophageal adenocarcinoma, inoperable stomach, mets gastric, multiiple myeloma, SCLC | Yes |
| XK469 | Chemotherapy | advanced solid tumors, Lymphoma | Yes |
| XK-469 | Chemotherapy | Other cancer | Yes |
| XIAP antisense | Chemotherapy | AML | Yes |
| Wobenzym | AIDS drug | No | |
| Warfarin Sodium | Ancillary Agent | See Remarks | |
| WX-UK1 | Chemotherapy | Gastric, ovarian, pancreatic cancer | Yes |
| WT-1 peptide vaccine | Biologic therapy (BRM, immunotherapy) | Pleura | See Remarks |
| WR 6026 | AIDS drug | No | |
| WR 2026 | Ancillary Agent | No | |
| WF10 | AIDS drug | Lymphoma | No |
| Vyxeos | Chemotherapy | Yes | |
| Vyloy | Biologic therapy (BRM, immunotherapy) | Stomach, GE junction | Yes |
| Vorinostat | Chemotherapy | advanced solid tumors, colorectal, CTCL, Leukemia, other cancer | Yes |
| Voriconazole | AIDS drug | AIDS, Opportunistic infection | No |
| Voraxase | Ancillary Agent | No | |
| Voranigo | Chemotherapy | CNS | Yes |
| Vonjo | Chemotherapy | Bone marrow | Yes |
| Volasertib | Chemotherapy | AML trials, Ovarian trials, Solid tumors trials | Yes |
| Vitaxin | Chemotherapy | Colorectal, other cancer | Yes |
| Vitamin E | Ancillary Agent | No | |
| Vitamin D | Ancillary Agent | No | |
| Vistogard | Ancillary Agent | No | |
| Vismodegib | Chemotherapy | Basal cell carcinoma, skin | Yes |
| Virulizin | Biologic therapy (BRM, immunotherapy) | Pancreatic cancer | Yes |
| Vinzolidine Sulfate | Chemotherapy | Yes |
